American College of Clinical Pharmacy
      Search      Cart
         

Clinical Reasoning Series in Pharmacotherapy, 2017 Home Study Edition





Gut Check Time: An Update in Gastrointestinal Pharmacotherapeutics

 

Series Overview

Clinical Reasoning Series is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Pharmacotherapy Specialist (BCPS).

 

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

 

Program Content

“Gut Check Time: An Update in Gastrointestinal Pharmacotherapeutics” has been approved by the Board of Pharmacy Specialties (BPS) for the recertification of Board Certified Pharmacotherapy Specialists (BCPSs). This year’s program focuses on contemporary strategies for the optimal management of patients with gastrointestinal conditions. It also explores best practices in the management of gastrointestinal pharmacotherapeutics. Sessions detail and apply evidence that helps inform individual patient care and advances pharmacist services.

 

“Gut Check Time: An Update in Gastrointestinal Pharmacotherapeutics” covers the following content:

  • Inflammatory Bowel Disease
  • Updates to the Management of Pain in Chronic Pancreatitis
  • Bariatric Surgery
  • Chronic Liver Disease
  • Opioid-induced Constipation
  • Irritable Bowel Syndrome
Faculty
Bernadette Asias-Dinh, Pharm.D., BCPS, CDE Bernadette Asias-Dinh, Pharm.D., BCPS, CDE
Clinical Assistant Professor
University of Houston College of Pharmacy
Houston, Texas
Amaris Fuentes, Pharm.D., BCPS, BCCCP Amaris Fuentes, Pharm.D., BCPS, BCCCP
Clinical Specialist
Houston Methodist Hospital
Houston, Texas
Bryan L. Love, Pharm.D., BCPS-AQ ID Bryan L. Love, Pharm.D., BCPS-AQ ID
Associate Professor
University of South Carolina College of Pharmacy
Columbia, South Carolina
Rima A. Mohammad, PharmD, FCCP, BCPS Rima A. Mohammad, PharmD, FCCP, BCPS
Clinical Pharmacist Specialist in General Surgery/Gastroenterology/Nutrition
Clinical Associate Professor in Pharmacy
University of Michigan College of Pharmacy
Ann Arbor, Michigan

 

Target Audience and Program Goals

Clinical pharmacists, BCPSs providing care to patients with gastrointestinal conditions.

 

At the conclusion of the program, the participant should be able to:

  1. Determine the best therapeutic option(s) in managing patients with liver disease, pancreatitis, irritable bowel syndrome, inflammatory bowel disease, opioid-induced constipation, or bariatric surgery.
  2. Discuss emerging diagnostic and therapeutic options in the management of liver disease, pancreatitis, irritable bowel syndrome, inflammatory bowel disease, opioid-induced constipation, or bariatric surgery.
  3. Manage the treatment and processes in transitions of care in patients with liver disease, pancreatitis, irritable bowel syndrome, inflammatory bowel disease, opioid-induced constipation, or bariatric surgery.
  4. Design an appropriate monitoring plan for patients with liver disease, pancreatitis, irritable bowel syndrome, inflammatory bowel disease, opioid-induced constipation, or bariatric surgery.
  5. Apply clinical and pharmacoeconomic data to individual patient care and formulary decisions regarding drugs used for liver disease, pancreatitis, irritable bowel syndrome, inflammatory bowel disease, opioid-induced constipation, or bariatric surgery.

 

Continuing Pharmacy Education Credit

ACPE The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This is an application-based activity; Activity Number: 0217-0000-17-207-H01-P.

 

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 10, 2020. Partial credit is not available for this activity.

BCPS Specialty Recertification Credit

To be eligible for 6.0 CPE hours of recertification credit, BCPS must attend all 6.0 contact hours of live programming and successfully complete a Web‐based posttest by December 31, 2017.

 

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

Technical Requirements

Requires an Internet browser and Adobe Reader.
 

Fees
Description Price Nonmember Cart
Specialty Recertification Program with 6.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is December 31, 2017.
$250 $365 Expired
Online Program with 6.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed. under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 10, 2020.
$199 $315